Noteworthy - Pharmaceutical Executive



Top Medical Innovations for 2014

November 1, 2013

At the conclusion of the Cleveland Clinic's Medical Innovations Summit each year, 10 innovative technologies are unveiled before the audience, and designated as new and revolutionary tools for the treatment of disease and disability.

Big Pharma's Newest Cost Center

October 31, 2013

As the burden of promotional disclosure expands beyond US shores, understanding the rules and then controlling the cost of compliance is a strategic necessity.

In the Digital Age, Don't Forget to G.O.Y.A

October 22, 2013

Digital devices have made it possible to conduct business without ever leaving your desk. But something is just plain old wrong with that, writes Al Topin.

Biopharma: The Elements of Training

October 4, 2013

Establishing a well-defined training program is a crucial activity for any biopharmaceutical organization, writes Susan J. Schniepp.

12th Annual Pharmaceutical Industry Audit

October 1, 2013

With revenues down and margins squeezed by a realigning payer pool, the power to price above the market is the ticket to the top—no discounts allowed.

Taking Stock: Notes on the Industry Audit

October 1, 2013

Our October issue highlights a latent threat to Big Pharma: the behavioral mindset that may be best characterized as "ageing in place."

Not Much Ado About the ACA

October 1, 2013

With key provisions of the Affordable Care Act set to launch this month, industry veteran Mason Tenaglia says the impact all depends on what you sell and where you sit.

Market Access is Dead

October 1, 2013

Patient access is the new driver of change and progress in healthcare marketing, says a senior industry player in market development.

Field Force Evolution: Adapting to a New Ecosystem

October 1, 2013

Environmental changes on all sides of professional sale are forcing biopharmaceutical companies to select for new traits in the makeup of the field force function.


Click here